Volume 25, Number 11—November 2019
Dispatch
Preventing Sexual Transmission of Zika Virus Infection during Pregnancy, Puerto Rico, USA, 20161
Table 2
Characteristic | Total, n = 1,794† |
||||||
---|---|---|---|---|---|---|---|
Any condom use |
Consistent condom use |
||||||
% Respondents (95% CI)‡ | Crude PR (95% CI) | Adjusted PR (95% CI)§ | % Respondents (95% CI)‡ | Crude PR (95% CI) | Adjusted PR (95% CI)§ | ||
Age, y | |||||||
<19 | 51.5 (43.9–59.0) | 1.62 (1.29–2.04) | 1.22 (0.96–1.54) | 24.5 (18.3–31.9) | 1.68 (1.12–2.53) | 1.13 (0.73–1.75) | |
20–34 | 41.8 (39.3–44.3) | 1.16 (0.95–1.40) | 0.99 (0.82–1.18) | 20.4 (18.4–22.5) | 1.12 (0.80–1.57) | 0.94 (0.67–1.31) | |
>35 |
42.4
(35.3–49.8) |
Referent¶ |
Referent |
21.7
(15.8–29.1) |
Referent# |
Referent |
|
Education level | |||||||
High school or less | 46.8 (42.4–51.4) | 1.24 (1.12–1.38) | 1.14 (1.02–1.27) | 25.2 (21.5–29.2) | 1.40 (1.17–1.69) | 1.31 (1.07–1.60) | |
More than high school |
41.1
(38.6–43.7) |
Referent |
Referent |
19.2
(17.1–21.5) |
Referent |
Referent |
|
Marital status during pregnancy | |||||||
Unmarried | 41.4 (38.8–44.1) | 1.03 (0.92–1.15) | 0.91 (0.82–1.02) | 20.4 (18.4–22.7) | 1.05 (0.88–1.26) | 0.93 (0.78–1.10) | |
Married |
45.3
(41.4–49.3) |
Referent |
Referent |
22.0
(18.9–25.3) |
Referent |
Referent |
|
Prenatal WIC program participation | |||||||
Yes, did not receive a Zika prevention kit | 41.6 (34.9–48.6) | 1.32 (1.02–1.71) | 1.29 (0.99–1.68) | 18.7 (14.1–24.3) | 1.08 (0.72–1.61) | 0.96 (0.64–1.43) | |
Yes, received a Zika prevention kit | 44.5 (41.9–47.1) | 1.52 (1.23–1.87) | 1.38 (1.12–1.70) | 21.4 (19.3–23.7) | 1.36 (1.00–1.86) | 1.10 (0.80–1.51) | |
No |
32.3
(26.2–39.0) |
Referent |
Referent |
19.5
(14.4–26.0) |
Referent |
Referent |
|
Prepregnancy condom use | |||||||
Yes | 64.7 (57.5–71.2) | 1.64 (1.45–1.85) | 1.60 (1.42–1.80) | 34.7 (28.2–41.9) | 1.84 (1.48–2.28) | 1.78 (1.44–2.21) | |
No** |
40.5
(38.2–42.8) |
Referent |
Referent |
19.5
(17.7–21.4) |
Referent |
Referent |
|
Received counseling on condom use to prevent Zika | |||||||
Yes | 45.9 (43.4–48.4) | 2.57 (1.99–3.32) | 2.25 (1.73–2.91) | 22.8 (20.9–25.0) | 3.28 (2.12–5.09) | 3.07 (1.97–4.79) | |
No | 20.4 (15.7–26.0) | Referent | Referent | 7.4 (4.8–11.4) | Referent | Referent |
*PR, prevalence ratio; WIC, Special Supplemental Nutrition Program for Women, Infants, and Children.
†Unweighted sample size.
‡Adjusted weighted percentage.
§All prevalence and prevalence ratio estimates were adjusted for maternal age, education, marital status, prenatal WIC participation, receipt of provider counseling, infant birth month, and region.
¶Adjusted p value (<0.01) for linear trend based on maternal age.
#Adjusted p value (<0.05) for linear trend based on maternal age.
**Included women who reported they were not doing anything to prevent pregnancy and women who were using a contraceptive method other than condoms to prevent pregnancy.
1Preliminary results from this study were presented at the 2018 American Public Health Association Annual Meeting in San Diego, California, USA, November 10–14, 2018.